Details
Stereochemistry | MIXED |
Molecular Formula | C16H22O3 |
Molecular Weight | 262.3441 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1CC(CC(C)(C)C1)OC(=O)C2=C(O)C=CC=C2
InChI
InChIKey=WSSJONWNBBTCMG-UHFFFAOYSA-N
InChI=1S/C16H22O3/c1-11-8-12(10-16(2,3)9-11)19-15(18)13-6-4-5-7-14(13)17/h4-7,11-12,17H,8-10H2,1-3H3
Molecular Formula | C16H22O3 |
Molecular Weight | 262.3441 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM258718.pdf
Curator's Comment: http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM258718.pdf
Homosalate is used as a broad-band UV filter in concentrations of up to 10% in the EU or 15% depending upon where the product is used (e.g. in the USA) in sunscreen products alone or in combination with other UV absorbers to protect the skin against harmful effects of the UV radiation.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Korean women: breast cancer knowledge, attitudes and behaviors. | 2001 |
|
Determination of the UV filters worldwide authorised in sunscreens by high-performance liquid chromatography. Use of cyclodextrins as mobile phase modifier. | 2001 Jul 6 |
|
In vitro and in vivo estrogenicity of UV screens. | 2001 Mar |
|
Determination of sixteen UV filters in suncare formulations by high-performance liquid chromatography. | 2004 Sep 17 |
|
Influence of anatomical site and topical formulation on skin penetration of sunscreens. | 2005 Sep |
|
3,3,5-Trimethylcyclohexanols and derived esters: green synthetic procedures, odour evaluation and in vitro skin cytotoxicity assays. | 2006 Dec |
|
Design of a photostabilizer having built-in antioxidant functionality and its utility in obtaining broad-spectrum sunscreen formulations. | 2006 May-Jun |
|
Quercetin and rutin as potential sunscreen agents: determination of efficacy by an in vitro method. | 2008 Jun |
|
Non-porous membrane-assisted liquid-liquid extraction of UV filter compounds from water samples. | 2009 Jun 12 |
|
On-line renewable solid-phase extraction hyphenated to liquid chromatography for the determination of UV filters using bead injection and multisyringe-lab-on-valve approach. | 2010 May 28 |
|
Simultaneous determination of the UV-filters benzyl salicylate, phenyl salicylate, octyl salicylate, homosalate, 3-(4-methylbenzylidene) camphor and 3-benzylidene camphor in human placental tissue by LC-MS/MS. Assessment of their in vitro endocrine activity. | 2013 Oct 1 |
|
FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1. | 2013 Sep 5 |
Patents
Sample Use Guides
In Vivo Use Guide
Curator's Comment: 30 min after application the remaining product was removed from the skin with two dry cotton swabs and the skin was tape-stripped 16 times with D-Squames. The total amount of UV filters penetrating into the stratum corneum (strips 2–16) from the emulsion gel formulation was 25.7+/-6.4 ug/cm2 (23.2 % applied dose). The total amount of UV filters penetrating from the petroleum formulation was 8.3+/-3.6 ug/cm2 (9.0 % applied dose).
2 mg/cm2 Homosalate was applied to area (2x2 cm) on the volar side of the forearm.
Route of Administration:
Other
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/12566826
Human full-thickness skin was mounted in a conventional static Franz diffusion cells with a receptor volume of 12.4 ml. The UV filters were readily soluble in the receptor fluid. Epidermis and dermis separated by the hot plate method
(60°C for 2 min) and punch biopsies (8 mm) from the tissue samples were taken. Homosalate did not permeate through the skin after 6 h application.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sun Dec 18 18:28:28 UTC 2022
by
admin
on
Sun Dec 18 18:28:28 UTC 2022
|
Record UNII |
V06SV4M95S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 352.10
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
||
|
CFR |
21 CFR 352.20
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
||
|
EPA PESTICIDE CODE |
76603
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
||
|
NCI_THESAURUS |
C851
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3183
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
C060446
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
C83760
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
204-260-8
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
DTXSID1026241
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
CHEMBL1377575
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
91326
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | RxNorm | ||
|
1311408
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
V06SV4M95S
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
164918
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
DB11064
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
HOMOSALATE
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
KK-99
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
SUB08053MIG
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
8362
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
118-56-9
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
M6047
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | Merck Index | ||
|
3279
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY | |||
|
V06SV4M95S
Created by
admin on Sun Dec 18 18:28:28 UTC 2022 , Edited by admin on Sun Dec 18 18:28:28 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |